BACKGROUND

The number of end-stage renal disease patients with diabetes mellitus (DM) who are undergoing peritoneal dialysis is increasing. Peritoneal dialysis-associated peritonitis (PDAP) is a serious complication of peritoneal dialysis leading to technical failure and increased mortality in patients undergoing peritoneal dialysis. The profile of clinical symptoms, distribution of pathogenic organisms, and response of PDAP to medical management in the subset of end-stage renal disease patients with DM have not been reported previously. Discrepant results have been found in long-term prognostic outcomes of PDAP in patients with DM. We inferred that DM is associated with bad outcomes in PDAP patients.

AIM

To compare the clinical features and outcomes of PDAP between patients with DM and those without.

METHODS

In this multicenter retrospective cohort study, we enrolled patients who had at least one episode of PDAP during the study period. The patients were followed for a median of 31.1 mo. They were divided into a DM group and a non-DM group. Clinical features, therapeutic outcomes, and long-term prognostic outcomes were compared between the two groups. Risk factors associated with therapeutic outcomes of PDAP were analyzed using multivariable logistic regression. A Cox proportional hazards model was constructed to examine the influence of DM on patient survival and incidence of technical failure.

RESULTS

Overall, 373 episodes occurred in the DM group ( = 214) and 692 episodes occurred in the non-DM group ( = 395). The rates of abdominal pain and fever were similar in the two groups ( > 0.05). The DM group had more infections with coagulase-negative Staphylococcus and less infections with () as compared to the non-DM group ( < 0.05). Multivariate logistic regression analysis revealed no association between the presence of diabetes and rates of complete cure, catheter removal, PDAP-related death, or relapse of PDAP ( > 0.05). Patients in the DM group were older and had a higher burden of cardiovascular disease, with lower level of serum albumin, but a higher estimated glomerular filtration rate ( < 0.05). Cox proportional hazards model confirmed that the presence of diabetes was a significant predictor of all-cause mortality (hazard ratio = 1.531, 95% confidence interval: 1.091-2.148, < 0.05), but did not predict the occurrence of technical failure ( > 0.05).

CONCLUSION

PDAP patients with diabetes have similar symptomology and are predisposed to coagulase-negative Staphylococcus but not infection compared those without. Diabetes is associated with higher all-cause mortality but not therapeutic outcomes of PDAP.